These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Severe hepatitis due to percutaneous diclofenac.
    Author: Yerly G, Cereda JM.
    Journal: Gastroenterol Clin Biol; 2008 Oct; 32(10):824-5. PubMed ID: 18818036.
    Abstract:
    Although it is rare, diclofenac, a nonsteroidal antiinflammatory drug, may cause severe liver damage,sometimes with a fatal outcome. We report the first case of a patient who developed severe reversible liver damage after a percutaneous administration of diclofenac.
    [Abstract] [Full Text] [Related] [New Search]